Homepage Category | DSInpharmatics

January 2, 2024

Published by Meranda Parascandola at January 2, 2024

12 Reasons You Should Invest in Biotech Consulting

Biotechnology firms are cropping up all over the place, and growing at an unbelievable rate. California alone is home to over 3,000 life sciences companies, employing over 287,000 people[1] and the global industry is expected to be worth $727.1 billion by 2025.[2]

January 16, 2024

Published by Meranda Parascandola at January 16, 2024

Harmonizing Global CMC Guidelines: A Roadmap to Streamlined Pharmaceutical Approvals

The pharmaceutical industry is growing through global collaboration and market expansion. To continue this growth, regulatory compliance for Chemistry, Manufacturing and Controls (CMC) must be followed. Without CMC regulatory compliance, the safety behind the creation of any products could be compromised. CMC regulatory compliance is a topic that DS Inpharmatics […]

January 17, 2024

Published by Meranda Parascandola at January 17, 2024

U.S. Pharma’s Roadmap to EMA Approval: IMPDs and MAAs Uncovered

Introduction U.S. companies face unique challenges and opportunities in the global race to develop and market new pharmaceuticals. A critical step in this journey is navigating the European Medicines Agency's (EMA) regulatory framework for Investigational Medicinal Product Dossier (IMPD) applications and Marketing Authorization Applications (MAAs). Understanding these processes is key […]

February 9, 2024

Published by Meranda Parascandola at February 9, 2024

The Evolving Role of Data Integrity in Pharmaceutical Quality Assurance

In the realm of pharmaceuticals, data integrity stands as a cornerstone, underpinning the veracity of scientific research, the efficacy of drug development, and the safety of patient outcomes. This critical facet of pharmaceutical quality assurance has evolved significantly, particularly in the wake of advancing technology and stringent regulatory standards. Our […]

March 14, 2024

Published by Meranda Parascandola at March 14, 2024

Strategies for Global Pharmaceutical Supply Chain Excellence: An Interview with Joseph P. Ivan

In this interview, NewsMed spoke with Joseph P. Ivan regarding the Comprehensive Assessment and Management Approach to Optimizing Pharmaceutical Supply Chains. How do you optimize supply chain strategies while navigating the complexities of international regulation guidelines? Navigating international regulations demands the employment of diverse strategies. While consolidating supplies into a […]

March 22, 2024

Published by Meranda Parascandola at March 22, 2024

The Impact of FDA Fast Track and Accelerated Approval on Drug Development

The FDA Fast Track and Accelerated Approval pathways can expedite the review of new drugs. It is important to understand these pathways and how they impact drug development, as well as other industries, like healthcare and pharmaceutics. FDA Fast Track Designation: Accelerating The Time During The Drug Development Process The […]